デフォルト表紙
市場調査レポート
商品コード
1458027

臨床栄養の世界市場調査レポート:産業分析、規模、シェア、成長、動向、2024年~2032年までの予測

Global Clinical Nutrition Market Research Report - Industry Analysis, Size, Share, Growth, Trends and Forecast 2024 to 2032

出版日: | 発行: Value Market Research | ページ情報: 英文 248 Pages | 納期: 即日から翌営業日

● お客様のご希望に応じて、既存データの加工や未掲載情報(例:国別セグメント)の追加などの対応が可能です。  詳細はお問い合わせください。

価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=157.14円
臨床栄養の世界市場調査レポート:産業分析、規模、シェア、成長、動向、2024年~2032年までの予測
出版日: 2024年03月01日
発行: Value Market Research
ページ情報: 英文 248 Pages
納期: 即日から翌営業日
  • 全表示
  • 概要
  • 図表
  • 目次
概要

臨床栄養市場の世界需要は、2023年の308億9,000万米ドルから2032年には535億8,000万米ドル近くの市場規模に達すると推定され、調査期間2024年~2032年のCAGRは6.31%です。

臨床栄養学は、病状を管理・予防するために食事戦略を用いる専門ヘルスケア分野です。この分野のヘルスケア専門家は、患者の栄養ニーズを評価し、不足に対処したり特定の健康目標をサポートしたりするための個別計画を策定します。病院、診療所、リハビリテーションセンターなど、さまざまな医療現場において、患者がより良い健康結果を得るために栄養摂取を最適化できるよう支援することが重要です。栄養士、医師、その他のヘルスケアプロバイダーが協力し、栄養を包括的な患者ケアに統合することが必要です。

市場力学

さまざまな健康状態の管理における栄養の重要性に対する意識の高まりが、臨床栄養製品に対する需要を促進しています。慢性疾患の増加や人口の高齢化は、専門的な栄養介入の採用拡大に寄与しています。栄養科学と技術の進歩により、多様な患者のニーズに応える個別化された標的化臨床栄養ソリューションの開発が可能になります。さらに、栄養不良の有病率の上昇、慢性疾患の増加、老年人口の拡大が市場の拡大に寄与しています。臨床栄養製品に革新的な成分や製剤を組み込むことで、その有効性と嗜好性が高まり、患者のアドヒアランスが促進されます。さらに、有利な償還政策と世界のヘルスケア支出の急増が市場の成長を刺激しています。ヘルスケアプロバイダーと栄養士のコラボレーションは、オーダーメイドの栄養ソリューションの提供をさらに強化します。

調査レポートは、ポーターのファイブフォースモデル、市場魅力度分析、バリューチェーン分析をカバーしています。これらのツールは、業界の構造を明確に把握し、世界レベルでの競合の魅力を評価するのに役立ちます。さらに、これらのツールは、臨床栄養の世界市場における各セグメントを包括的に評価することもできます。臨床栄養業界の成長と動向は、この研究に全体的なアプローチを提供します。

市場セグメンテーション

臨床栄養市場レポートのこのセクションでは、国および地域レベルのセグメントに関する詳細なデータを提供し、それによって戦略家は、今後の機会で、それぞれの製品やサービスのターゲット層を識別するのに役立ちます。

製品別

  • 経口臨床栄養
  • 非経口栄養(炭水化物、非経口脂質エマルジョン、単回投与アミノ酸溶液、微量元素、ビタミン&ミネラル)
  • 経腸栄養製剤(標準製剤、疾患特異的製剤)

適応症別

  • アルツハイマー
  • 栄養不足
  • がんケア
  • 糖尿病
  • 慢性腎臓病
  • 希少疾患
  • 嚥下障害
  • 疼痛管理
  • 吸収不良/ジー障害/下痢
  • その他

販売チャネル別

  • オンライン販売チャネル
  • 小売販売チャネル
  • 施設販売チャネル
  • 臨床栄養

地域分析

このセクションでは、北米、欧州、アジア太平洋、ラテンアメリカ、中東&アフリカにおける臨床栄養市場の現在および将来の需要を強調する地域展望をカバーしています。さらに、著名な全地域における個々のアプリケーションセグメントの需要・推定・予測にも焦点を当てています。

  • 地域別臨床栄養世界市場シェア(代表グラフ)
  • 臨床栄養の世界市場シェア

カスタムメイドのご要望がございましたら、弊社までご連絡ください。当社の調査チームは、お客様のニーズに応じてカスタマイズしたレポートを提供することができます。

目次

第1章 序文

第2章 エグゼクティブサマリー

  • 市場のハイライト
  • 世界市場スナップショット

第3章 臨床栄養-産業分析

  • イントロダクション:市場力学
  • 市場促進要因
  • 市場抑制要因
  • 機会
  • 業界動向
  • ポーターのファイブフォース分析
  • 市場魅力度分析

第4章 バリューチェーン分析

  • バリューチェーン分析
  • 原材料分析
    • 原材料リスト
    • 原材料メーカーリスト
    • 主要原材料の価格動向
  • 潜在的バイヤーのリスト
  • マーケティングチャネル
    • ダイレクトマーケティング
    • インダイレクトマーケティング
    • マーケティングチャネル発展動向

第5章 臨床栄養の世界市場分析:製品別

  • 製品別概要
  • 実績データと予測データ
  • 製品別分析
  • 経口臨床栄養
  • 非経口栄養(炭水化物、非経口脂質乳剤、単回投与アミノ酸溶液、微量元素、ビタミン・ミネラル)
  • 経腸栄養製剤(標準製剤、疾患特異的製剤)

第6章 臨床栄養の世界市場分析:適応症別

  • 適応症別概要
  • 実績データと予測データ
  • 適応症別分析
  • アルツハイマー
  • 栄養不足
  • がん治療
  • 糖尿病
  • 慢性腎臓病
  • 希少疾患
  • 嚥下障害
  • 疼痛管理
  • 吸収不良/胃腸障害/下痢
  • その他

第7章 臨床栄養の世界市場分析:販売チャネル別

  • 販売チャネル別概要
  • 実績データと予測データ
  • 販売チャネル別分析
  • オンライン販売チャネル
  • 小売販売チャネル
  • 施設販売チャネル
  • 臨床栄養

第8章 臨床栄養の世界市場分析:地域別

  • 地域別展望
  • イントロダクション
  • 北米売上分析
    • 概要、実績と予測
    • 北米:セグメント別
    • 北米:国別
    • 米国
    • カナダ
    • メキシコ
  • 欧州売上分析
    • 概要、実績と予測
    • 欧州:セグメント別
    • 欧州:国別
    • 英国
    • フランス
    • ドイツ
    • イタリア
    • ロシア
    • その他の欧州
  • アジア太平洋売上分析
    • 概要、実績と予測
    • アジア太平洋:セグメント別
    • アジア太平洋:国別
    • 中国
    • インド
    • 日本
    • 韓国
    • オーストラリア
    • 東南アジア
    • その他のアジア太平洋
  • ラテンアメリカ売上分析
    • 概要、実績と予測
    • ラテンアメリカ:セグメント別
    • ラテンアメリカ:国別
    • ブラジル
    • アルゼンチン
    • ペルー
    • チリ
    • その他のラテンアメリカ
  • 中東・アフリカ売上分析
    • 概要、実績と予測
    • 中東・アフリカ:セグメント別
    • 中東・アフリカ:国別
    • サウジアラビア
    • アラブ首長国連邦
    • イスラエル
    • 南アフリカ
    • その他の中東・アフリカ

第9章 臨床栄養企業の競合情勢

  • 臨床栄養市場の競合
  • 提携/協力/合意
  • 合併と買収
  • 新製品の発売
  • その他の開発

第10章 企業プロファイル

  • 企業シェア分析
  • 市場集中度
  • Abbott Nutrition
  • Pfizer Inc.
  • Bayer AG
  • Nestle
  • Baxter International Inc.
  • Otsuka Holdings Co. Ltd.
  • Mead Johnson & Company LLC
  • Danone(Nutricia)
  • Victus Inc.
  • Fresenius Kabi
  • Meiji Holdings. Co. Ltd.
  • Abbvie(Allergan)
  • Baxter
  • Grifols S.A.
図表

LIST OF TABLES

  • Market Snapshot
  • Drivers : Impact Analysis
  • Restraints : Impact Analysis
  • List of Raw Material
  • List of Raw Material Manufactures
  • List of Potential Buyers
  • Analysis by Product (USD MN)
  • Oral Clinical Nutrition Market Sales by Geography (USD MN)
  • Parenteral Nutrition (Carbohydrates, Parenteral Lipid Emulsion, Single Dose Amino Acid Solutions, Trace Elements, Vitamins & Minerals) Market Sales by Geography (USD MN)
  • Enteral Feeding Formulas (Standard Formula, Disease-specific Formulas) Market Sales by Geography (USD MN)
  • Analysis Market by Indication (USD MN)
  • Alzheimer's Market Sales by Geography (USD MN)
  • Nutrition Deficiency Market Sales by Geography (USD MN)
  • Cancer Care Market Sales by Geography (USD MN)
  • Diabetes Market Sales by Geography (USD MN)
  • Chronic Kidney Diseases Market Sales by Geography (USD MN)
  • Orphan Diseases Market Sales by Geography (USD MN)
  • Dysphagia Market Sales by Geography (USD MN)
  • Pain Management Market Sales by Geography (USD MN)
  • Malabsorption/GI Disorder/Diarrhea Market Sales by Geography (USD MN)
  • Others Market Sales by Geography (USD MN)
  • Analysis by Sales Channel (USD MN)
  • Online Sales Channels Market Sales by Geography (USD MN)
  • Retail Sales Channels Market Sales by Geography (USD MN)
  • Institutional Sales Channels Market Sales by Geography (USD MN)
  • Clinical Nutrition Market Sales by Geography (USD MN)
  • Global Clinical Nutrition Market Sales by Geography (USD MN)
  • North America Market Analysis (USD MN)
  • United State Market Analysis (USD MN)
  • Canada Market Analysis (USD MN)
  • Mexico Market Analysis (USD MN)
  • Europe Market Analysis (USD MN)
  • Europe Market Estimate by Country (USD MN)
  • United Kingdom Market Analysis (USD MN)
  • France Market Analysis (USD MN)
  • Germany Market Analysis (USD MN)
  • Italy Market Analysis (USD MN)
  • Russia Market Analysis (USD MN)
  • Spain Market Analysis (USD MN)
  • Rest of Europe Market Analysis (USD MN)
  • Asia Pacific Market Analysis (USD MN)
  • China Market Analysis (USD MN)
  • Japan Market Analysis (USD MN)
  • India Market Analysis (USD MN)
  • South Korea Market Analysis (USD MN)
  • Australia Market Analysis (USD MN)
  • South East Asia Market Analysis (USD MN)
  • Rest of Asia Pacific Market Analysis (USD MN)
  • Latin America Market Analysis (USD MN)
  • Brazil Market Analysis (USD MN)
  • Argentina Market Analysis (USD MN)
  • Peru Market Analysis (USD MN)
  • Chile Market Analysis (USD MN)
  • Rest of Latin America Market Analysis (USD MN)
  • Middle East & Africa Market Analysis (USD MN)
  • Saudi Arabia Market Analysis (USD MN)
  • UAE Market Analysis (USD MN)
  • Israel Market Analysis (USD MN)
  • South Africa Market Analysis (USD MN)
  • Rest of Middle East and Africa Market Analysis (USD MN)
  • Partnership/Collaboration/Agreement
  • Mergers And Acquisition

LIST OF FIGURES

  • Research Scope of Clinical Nutrition Report
  • Market Research Process
  • Market Research Methodology
  • Global Clinical Nutrition Market Size, by Region (USD MN)
  • Porters Five Forces Analysis
  • Market Attractiveness Analysis by Product
  • Market Attractiveness Analysis by Indication
  • Market Attractiveness Analysis by Sales Channel
  • Market Attractiveness Analysis by Region
  • Value Chain Analysis
  • Global Market Analysis by Product (USD MN)
  • Oral Clinical Nutrition Market Sales by Geography (USD MN)
  • Parenteral Nutrition (Carbohydrates, Parenteral Lipid Emulsion, Single Dose Amino Acid Solutions, Trace Elements, Vitamins & Minerals) Market Sales by Geography (USD MN)
  • Enteral Feeding Formulas (Standard Formula, Disease-specific Formulas) Market Sales by Geography (USD MN)
  • Global Market Analysis by Indication (USD MN)
  • Alzheimer's Market Sales by Geography (USD MN)
  • Nutrition Deficiency Market Sales by Geography (USD MN)
  • Cancer Care Market Sales by Geography (USD MN)
  • Diabetes Market Sales by Geography (USD MN)
  • Chronic Kidney Diseases Market Sales by Geography (USD MN)
  • Orphan Diseases Market Sales by Geography (USD MN)
  • Dysphagia Market Sales by Geography (USD MN)
  • Pain Management Market Sales by Geography (USD MN)
  • Malabsorption/GI Disorder/Diarrhea Market Sales by Geography (USD MN)
  • Others Market Sales by Geography (USD MN)
  • Global Market Analysis by Sales Channel (USD MN)
  • Online Sales Channels Market Sales by Geography (USD MN)
  • Retail Sales Channels Market Sales by Geography (USD MN)
  • Institutional Sales Channels Market Sales by Geography (USD MN)
  • Clinical Nutrition Market Sales by Geography (USD MN)
  • Global Market Sales (USD MN)
  • North America Market Sales (USD MN)
  • Europe Market Sales (USD MN)
  • Asia Pacific Market Sales (USD MN)
  • Latin America Market Sales (USD MN)
  • Middle East & Africa Market Sales (USD MN)
  • Recent Development in Industry
  • Top Company Market Share Analysis

Kindly note that the above listed are the basic tables and figures of the report and are not limited to the TOC.

目次
Product Code: VMR112113875

The global demand for Clinical Nutrition Market is presumed to reach the market size of nearly USD 53.58 BN by 2032 from USD 30.89 BN in 2023 with a CAGR of 6.31% under the study period 2024 - 2032.

Clinical nutrition is a specialized healthcare field that uses dietary strategies to manage and prevent medical conditions. Healthcare professionals in this field assess patients' nutritional needs and develop personalized plans to address deficiencies or support specific health goals. It is crucial in various medical settings, including hospitals, clinics, and rehabilitation centers, to help patients optimize their nutritional intake for better health outcomes. It involves collaboration among dietitians, physicians, and other healthcare providers to integrate nutrition into comprehensive patient care.

MARKET DYNAMICS

Escalating awareness of the importance of nutrition in managing various health conditions fuels the demand for clinical nutrition products. Escalating incidences of chronic diseases and an aging population contribute to the increased adoption of specialized nutritional interventions. Advancements in nutritional science and technology enable the development of personalized and targeted clinical nutrition solutions catering to diverse patient needs. Moreover, the escalating prevalence of malnutrition, the rise in chronic illnesses, and the expanding geriatric population contribute to the market's expansion. Integrating innovative ingredients and formulations in clinical nutrition products enhances their effectiveness and palatability, promoting patient adherence. Furthermore, favorable reimbursement policies and a surge in healthcare expenditure globally stimulate market growth. Collaborations between healthcare providers and nutritionists further strengthen the delivery of tailored nutrition solutions.

The research report covers Porter's Five Forces Model, Market Attractiveness Analysis, and Value Chain analysis. These tools help to get a clear picture of the industry's structure and evaluate the competition attractiveness at a global level. Additionally, these tools also give an inclusive assessment of each segment in the global market of clinical nutrition. The growth and trends of clinical nutrition industry provide a holistic approach to this study.

MARKET SEGMENTATION

This section of the clinical nutrition market report provides detailed data on the segments at country and regional level, thereby assisting the strategist in identifying the target demographics for the respective product or services with the upcoming opportunities.

By Product

  • Oral Clinical Nutrition
  • Parenteral Nutrition (Carbohydrates, Parenteral Lipid Emulsion, Single Dose Amino Acid Solutions, Trace Elements, Vitamins & Minerals)
  • Enteral Feeding Formulas (Standard Formula, Disease-Specific Formulas)

By Indication

  • Alzheimer's
  • Nutrition Deficiency
  • Cancer Care
  • Diabetes
  • Chronic Kidney Diseases
  • Orphan Diseases
  • Dysphagia
  • Pain Management
  • Malabsorption/Gi Disorder/Diarrhea
  • Others

By Sales Channel

  • Online Sales Channels
  • Retail Sales Channels
  • Institutional Sales Channels
  • Clinical Nutrition

REGIONAL ANALYSIS

This section covers the regional outlook, which accentuates current and future demand for the Clinical Nutrition market across North America, Europe, Asia-Pacific, Latin America, and Middle East & Africa. Further, the report focuses on demand, estimation, and forecast for individual application segments across all the prominent regions.

  • GLOBAL CLINICAL NUTRITION MARKET SHARE BY REGION (REPRESENTATIVE GRAPH)
  • Global Clinical Nutrition Market Share

The research report also covers the comprehensive profiles of the key players in the market and an in-depth view of the competitive landscape worldwide. The major players in the Clinical Nutrition market include Abbott Nutrition, Pfizer Inc., Bayer AG, Nestle, Baxter International Inc., Otsuka Holdings Co. Ltd., Mead Johnson & Company, LLC, Danone (Nutricia), Victus Inc., Fresenius Kabi, Meiji Holdings. Co. Ltd., Abbvie (Allergan), Baxter, Grifols S.A. This section consists of a holistic view of the competitive landscape that includes various strategic developments such as key mergers & acquisitions, future capacities, partnerships, financial overviews, collaborations, new product developments, new product launches, and other developments.

In case you have any custom requirements, do write to us. Our research team can offer a customized report as per your need.

TABLE OF CONTENTS

1 . PREFACE

  • 1.1. Report Description
    • 1.1.1. Objective
    • 1.1.2. Target Audience
    • 1.1.3. Unique Selling Proposition (USP) & offerings
  • 1.2. Research Scope
  • 1.3. Research Methodology
    • 1.3.1. Market Research Process
    • 1.3.2. Market Research Methodology

2 . EXECUTIVE SUMMARY

  • 2.1. Highlights of Market
  • 2.2. Global Market Snapshot

3 . CLINICAL NUTRITION - INDUSTRY ANALYSIS

  • 3.1. Introduction - Market Dynamics
  • 3.2. Market Drivers
  • 3.3. Market Restraints
  • 3.4. Opportunities
  • 3.5. Industry Trends
  • 3.6. Porter's Five Force Analysis
  • 3.7. Market Attractiveness Analysis
    • 3.7.1 Market Attractiveness Analysis By Product
    • 3.7.2 Market Attractiveness Analysis By Indication
    • 3.7.3 Market Attractiveness Analysis By Sales Channel
    • 3.7.4 Market Attractiveness Analysis By Region

4 . VALUE CHAIN ANALYSIS

  • 4.1. Value Chain Analysis
  • 4.2. Raw Material Analysis
    • 4.2.1. List of Raw Materials
    • 4.2.2. Raw Material Manufactures List
    • 4.2.3. Price Trend of Key Raw Materials
  • 4.3. List of Potential Buyers
  • 4.4. Marketing Channel
    • 4.4.1. Direct Marketing
    • 4.4.2. Indirect Marketing
    • 4.4.3. Marketing Channel Development Trend

5 . GLOBAL CLINICAL NUTRITION MARKET ANALYSIS BY PRODUCT

  • 5.1 Overview by Product
  • 5.2 Historical and Forecast Data
  • 5.3 Analysis by Product
  • 5.4 Oral Clinical Nutrition Historic and Forecast Sales by Regions
  • 5.5 Parenteral Nutrition (Carbohydrates, Parenteral Lipid Emulsion, Single Dose Amino Acid Solutions, Trace Elements, Vitamins & Minerals) Historic and Forecast Sales by Regions
  • 5.6 Enteral Feeding Formulas (Standard Formula, Disease-specific Formulas) Historic and Forecast Sales by Regions

6 . GLOBAL CLINICAL NUTRITION MARKET ANALYSIS BY INDICATION

  • 6.1 Overview by Indication
  • 6.2 Historical and Forecast Data
  • 6.3 Analysis by Indication
  • 6.4 Alzheimer's Historic and Forecast Sales by Regions
  • 6.5 Nutrition Deficiency Historic and Forecast Sales by Regions
  • 6.6 Cancer Care Historic and Forecast Sales by Regions
  • 6.7 Diabetes Historic and Forecast Sales by Regions
  • 6.8 Chronic Kidney Diseases Historic and Forecast Sales by Regions
  • 6.9 Orphan Diseases Historic and Forecast Sales by Regions
  • 6.10. Dysphagia Historic and Forecast Sales by Regions
  • 6.11 Pain Management Historic and Forecast Sales by Regions
  • 6.12 Malabsorption/GI Disorder/Diarrhea Historic and Forecast Sales by Regions
  • 6.13 Others Historic and Forecast Sales by Regions

7 . GLOBAL CLINICAL NUTRITION MARKET ANALYSIS BY SALES CHANNEL

  • 7.1 Overview by Sales Channel
  • 7.2 Historical and Forecast Data
  • 7.3 Analysis by Sales Channel
  • 7.4 Online Sales Channels Historic and Forecast Sales by Regions
  • 7.5 Retail Sales Channels Historic and Forecast Sales by Regions
  • 7.6 Institutional Sales Channels Historic and Forecast Sales by Regions
  • 7.7 Clinical Nutrition Historic and Forecast Sales by Regions

8 . GLOBAL CLINICAL NUTRITION MARKET ANALYSIS BY GEOGRAPHY

  • 8.1. Regional Outlook
  • 8.2. Introduction
  • 8.3. North America Sales Analysis
    • 8.3.1. Overview, Historic and Forecast Data Sales Analysis
    • 8.3.2. North America By Segment Sales Analysis
    • 8.3.3. North America By Country Sales Analysis
    • 8.3.4. United State Sales Analysis
    • 8.3.5. Canada Sales Analysis
    • 8.3.6. Mexico Sales Analysis
  • 8.4. Europe Sales Analysis
    • 8.4.1. Overview, Historic and Forecast Data Sales Analysis
    • 8.4.2. Europe by Segment Sales Analysis
    • 8.4.3. Europe by Country Sales Analysis
    • 8.4.4. United Kingdom Sales Analysis
    • 8.4.5. France Sales Analysis
    • 8.4.6. Germany Sales Analysis
    • 8.4.7. Italy Sales Analysis
    • 8.4.8. Russia Sales Analysis
    • 8.4.9. Rest Of Europe Sales Analysis
  • 8.5. Asia Pacific Sales Analysis
    • 8.5.1. Overview, Historic and Forecast Data Sales Analysis
    • 8.5.2. Asia Pacific by Segment Sales Analysis
    • 8.5.3. Asia Pacific by Country Sales Analysis
    • 8.5.4. China Sales Analysis
    • 8.5.5. India Sales Analysis
    • 8.5.6. Japan Sales Analysis
    • 8.5.7. South Korea Sales Analysis
    • 8.5.8. Australia Sales Analysis
    • 8.5.9. South East Asia Sales Analysis
    • 8.5.10. Rest Of Asia Pacific Sales Analysis
  • 8.6. Latin America Sales Analysis
    • 8.6.1. Overview, Historic and Forecast Data Sales Analysis
    • 8.6.2. Latin America by Segment Sales Analysis
    • 8.6.3. Latin America by Country Sales Analysis
    • 8.6.4. Brazil Sales Analysis
    • 8.6.5. Argentina Sales Analysis
    • 8.6.6. Peru Sales Analysis
    • 8.6.7. Chile Sales Analysis
    • 8.6.8. Rest of Latin America Sales Analysis
  • 8.7. Middle East & Africa Sales Analysis
    • 8.7.1. Overview, Historic and Forecast Data Sales Analysis
    • 8.7.2. Middle East & Africa by Segment Sales Analysis
    • 8.7.3. Middle East & Africa by Country Sales Analysis
    • 8.7.4. Saudi Arabia Sales Analysis
    • 8.7.5. UAE Sales Analysis
    • 8.7.6. Israel Sales Analysis
    • 8.7.7. South Africa Sales Analysis
    • 8.7.8. Rest Of Middle East And Africa Sales Analysis

9 . COMPETITIVE LANDSCAPE OF THE CLINICAL NUTRITION COMPANIES

  • 9.1. Clinical Nutrition Market Competition
  • 9.2. Partnership/Collaboration/Agreement
  • 9.3. Merger And Acquisitions
  • 9.4. New Product Launch
  • 9.5. Other Developments

10 . COMPANY PROFILES OF CLINICAL NUTRITION INDUSTRY

  • 10.1. Company Share Analysis
  • 10.2. Market Concentration Rate
  • 10.3. Abbott Nutrition
    • 10.3.1. Company Overview
    • 10.3.2. Company Revenue
    • 10.3.3. Products
    • 10.3.4. Recent Developments
  • 10.4. Pfizer Inc.
    • 10.4.1. Company Overview
    • 10.4.2. Company Revenue
    • 10.4.3. Products
    • 10.4.4. Recent Developments
  • 10.5. Bayer AG
    • 10.5.1. Company Overview
    • 10.5.2. Company Revenue
    • 10.5.3. Products
    • 10.5.4. Recent Developments
  • 10.6. Nestle
    • 10.6.1. Company Overview
    • 10.6.2. Company Revenue
    • 10.6.3. Products
    • 10.6.4. Recent Developments
  • 10.7. Baxter International Inc.
    • 10.7.1. Company Overview
    • 10.7.2. Company Revenue
    • 10.7.3. Products
    • 10.7.4. Recent Developments
  • 10.8. Otsuka Holdings Co. Ltd.
    • 10.8.1. Company Overview
    • 10.8.2. Company Revenue
    • 10.8.3. Products
    • 10.8.4. Recent Developments
  • 10.9. Mead Johnson & Company LLC
    • 10.9.1. Company Overview
    • 10.9.2. Company Revenue
    • 10.9.3. Products
    • 10.9.4. Recent Developments
  • 10.10. Danone (Nutricia)
    • 10.10.1. Company Overview
    • 10.10.2. Company Revenue
    • 10.10.3. Products
    • 10.10.4. Recent Developments
  • 10.11. Victus Inc.
    • 10.11.1. Company Overview
    • 10.11.2. Company Revenue
    • 10.11.3. Products
    • 10.11.4. Recent Developments
  • 10.12. Fresenius Kabi
    • 10.12.1. Company Overview
    • 10.12.2. Company Revenue
    • 10.12.3. Products
    • 10.12.4. Recent Developments
  • 10.13. Meiji Holdings. Co. Ltd.
    • 10.13.1. Company Overview
    • 10.13.2. Company Revenue
    • 10.13.3. Products
    • 10.13.4. Recent Developments
  • 10.14. Abbvie (Allergan)
    • 10.14.1. Company Overview
    • 10.14.2. Company Revenue
    • 10.14.3. Products
    • 10.14.4. Recent Developments
  • 10.15. Baxter
    • 10.15.1. Company Overview
    • 10.15.2. Company Revenue
    • 10.15.3. Products
    • 10.15.4. Recent Developments
  • 10.16. Grifols S.A.
    • 10.16.1. Company Overview
    • 10.16.2. Company Revenue
    • 10.16.3. Products
    • 10.16.4. Recent Developments

Note - in company profiling, financial details and recent development are subject to availability or might not be covered in case of private companies